Background/Objectives: This study evaluated autologous platelet concentrates (APCs), including advanced platelet-rich fibrin (A-PRF+) and concentrated growth factors (CGFs), as biologically active matrices, and photobiomodulation (PBM) as a biophysical stimulus affecting soft and hard tissue regeneration following mandibular third molar extraction. Methods: A six-arm parallel randomised controlled trial was conducted including 135 patients. A total of 122 participants completed follow-up and were analysed: control (n = 22), photobiomodulation (n = 20), A-PRF+ (n = 19), CGF (n = 20), A-PRF+ plus photobiomodulation (n = 22), and CGF plus photobiomodulation (n = 19). The primary endpoint was postoperative pain intensity assessed on postoperative day 3 using an 11-point visual analogue scale (VAS). Secondary outcomes included swelling, trismus, wound healing assessed by the early healing index, and bone regeneration assessed by CBCT-based fractal dimension analysis at 4 months. Results: On postoperative day 3, mean VAS pain was 2.95 ± 2.65 in the control group and 1.00 ± 1.65 in the photobiomodulation group, corresponding to a mean difference of 1.95 VAS points. The overall between-group difference for day 3 pain was statistically significant. In swelling outcomes, no statistically significant between-group differences were observed at days 1, 3, or 7 across facial measurement lines. In CBCT fractal analysis, a significant group effect was detected for the mid socket region, with higher fractal dimension at 4 months in the CGF plus photobiomodulation group compared with the control. Conclusions: Both APCs and PBM positively influenced postoperative healing. Their combined application, particularly CGF with PBM, showed the most consistent regenerative effects, although not all outcomes differed significantly between groups. These minimally invasive strategies may support soft and hard tissue regeneration.

Vitamin D plays an important role in bone metabolism and may influence postoperative healing processes. This study evaluated the association between preoperative serum vitamin D levels and recovery after mandibular third molar extraction. This secondary exploratory analysis included 122 healthy patients undergoing surgical extraction of an impacted mandibular third molar, of whom 98 had complete datasets for clinical and radiographic evaluation. Postoperative outcomes included pain intensity, facial swelling, trismus, early soft tissue healing assessed with the Wachtel Early Healing Index, and bone regeneration evaluated four months after surgery using CBCT-based fractal dimension analysis. Serum vitamin D levels were not significantly associated with postoperative pain, trismus, or early soft tissue healing. A weak correlation was observed between lower vitamin D levels and greater swelling along the tragus–pogonion line on postoperative day 1 (ρ = −0.21, p = 0.035), with no significant associations at later time points. Fractal dimension analysis did not demonstrate significant differences between groups. Within the limitations of this secondary exploratory analysis, vitamin D levels showed limited and inconsistent associations with postoperative outcomes, and their clinical relevance remains uncertain.

Titanium dental implants are widely regarded as the gold standard for the rehabilitation of missing teeth due to their high survival rates and favorable mechanical properties. However, in the oral environment, implant materials are continuously exposed to complex chemical, mechanical, and biological factors that may lead to surface degradation, including corrosion, tribocorrosion, and mechanical wear. These processes can alter implant surface characteristics and influence biological responses in peri-implant tissues. Zirconia implants have been introduced as alternative material due to their favorable aesthetics and biocompatibility. Nevertheless, zirconia ceramics are also susceptible to degradation phenomena, including hydrothermal aging, phase transformation, and surface wear under specific conditions, although their clinical relevance remains unclear. In addition, emerging hybrid titanium–zirconia implant systems introduce new considerations regarding surface stability. This scoping review, conducted in accordance with PRISMA-ScR guidelines, summarizes the current evidence on degradation mechanisms affecting titanium, zirconia, and hybrid dental implants, with particular focus on processes occurring in the oral environment and their biological and clinical implications. The available evidence differs substantially between the two materials. While titanium degradation is well documented and supported by both experimental and clinical studies, the evidence for a hybrid implant remains limited and is largely based on in vitro and mechanistic data.

Background/Objectives: The rising global prevalence of inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, has resulted in an increase in the number of affected patients requiring dental care. The heightened risk of Clostridioides difficile infection (CDI) in IBD patients, particularly when exposed to commonly used dental antibiotics, is attributable to their altered gut microbiota and frequent immunosuppressive therapy. The objective of this review is to evaluate current antibiotic strategies for dental management in IBD and to identify safe and effective alternatives that minimise CDI risk. Methods: A narrative review was conducted in accordance with the SANRA guidelines. A comprehensive analysis of literature sourced from PubMed, Embase, Scopus, and Google Scholar was conducted. Results: The available evidence suggests that first- and second-line dental antibiotics—amoxicillin, ampicillin, and clindamycin—carry the highest risk of CDI. In contrast, metronidazole, which exhibits a comparable antimicrobial spectrum, has been shown to possess significantly reduced CDI potential and minimal disruption of gut microbiota. The utilisation of emerging local delivery systems, such as platelet-rich fibrin (PRF), has the potential to further reduce systemic antibiotic exposure. The adjunctive use of probiotics, prebiotics and synbiotics has been demonstrated to have the capacity to maintain microbial balance during therapy. Conclusions: Tailored, microbiome-conscious antibiotic strategies are essential in dental management of IBD patients. Further clinical research is needed to develop evidence-based guidelines and validate promising adjunctive approaches.

Background/Objectives: Autism spectrum disorder (ASD) is associated with a higher prevalence of oral health problems, including parafunctional habits and malocclusions, which may lead to increased orthodontic treatment needs. The objective of this study was to evaluate orthodontic disorders and treatment requirements in children with ASD compared to their neurotypical peers. Methods: A cross-sectional study was conducted on 148 children aged 3–12 years, including 74 children with ASD and 74 controls matched for age and sex. Data were collected via caregiver questionnaires and clinical dental examinations. Malocclusions and orthodontic treatment requirements were assessed using the Index of Orthodontic Treatment Need (IOTN), including both the Dental Health Component (DHC) and Aesthetic Component (AC). Statistical analyses included Mann–Whitney U tests, Student’s t-tests, and effect size calculations, with significance set at p ≤ 0.05. Results: Children with ASD exhibited significantly higher orthodontic treatment needs compared to controls, with elevated scores in both IOTN-DHC (p < 0.001) and IOTN-AC (p < 0.001). No significant differences were observed for the mean overjet or overbite between groups. Gender analysis revealed that boys with ASD had significantly higher scores in both IOTN-DHC and IOTN-AC, while girls with ASD differed from controls only in IOTN-AC. Conclusions: Children with ASD are at increased risk for orthodontic treatment, particularly for both health and aesthetic needs, with boys showing the most pronounced disparities. These findings highlight the importance of early orthodontic assessment and tailored preventive strategies in this population.

Obesity is a heterogeneous multisystem condition characterized by chronic low-grade inflammation, oxidative stress, adipokine dysregulation, and insulin resistance; its effects on oral microbial homeostasis, tissue regeneration, and disease susceptibility vary with metabolic context and with the outcome examined. This narrative review synthesizes evidence on the mechanisms linking obesity to oral disease and on its implications for dental prevention, periodontal care, implant therapy, and oral surgery. MEDLINE via PubMed, Scopus, and Web of Science Core Collection were searched from January 2000 to 31 August 2026, with the final search performed on 10 September 2026. The strength of evidence differs markedly by outcome. Human epidemiological studies support an association with periodontitis; altered salivary flow and composition are reported mainly in cross-sectional studies. Proposed effects on osseous healing and jawbone remodeling rest substantially on experimental and systemic bone research, and specific marrow alterations remain poorly established. Obesity is associated with selected peri-implant inflammatory outcomes, whereas evidence on implant survival is less consistent; these findings establish neither impaired primary osseointegration nor a contraindication to implant therapy. Associations with caries appear largely attributable to shared determinants. The phenotype-aware framework proposed here is hypothesis-generating and requires prospective interventional validation.